In-vitro antibacterial activity of omeprazole and esomeprazole in combination with ciprofloxacin as an alternative to repositioning against ESKAPE pathogens and evaluation of the cleavage capacity of plasmid DNA

Saved in:
Bibliographic Details
Published inInternational journal of antimicrobial agents Vol. 61; no. 5; p. 106753
Main Authors da Rosa, Taciéli F., Foletto, Vitória S., Serafin, Marissa B., de Paula, Bruno R., Franco, Laísa N., Marion, Sara de L., da Mota, Augusto D., Hörner, Rosmari
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.05.2023
Subjects
Anti-Bacterial Agents - pharmacology
Ciprofloxacin - pharmacology
DNA
Esomeprazole - pharmacology
Omeprazole - pharmacology
Plasmids
Proton Pump Inhibitors - pharmacology
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2023.106753